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Abstract: The cinchona alkaloid-catalysed enantioselective formal 
[4+2]-cycloaddition of ethyl 2,3-butadienoate with a range of 1,1,1-
trifluoro- and 4,4,4-trifluorobutenones is investigated for the 
preparation of stereodefined C(6) – and C(4)-trifluoromethyl 
substituted dihydropyrans. Quinidine proved the optimal catalyst, 
generating the desired products in up to 98% ee and 81% yield. 
Stereo- and chemoselective derivatization of the dihydropyrans 
through hydrogenation is explored. 
Introduction 
Allenoates are versatile synthetic building blocks that are widely 
used in the synthesis of carbo- and heterocyclic products.[1] 
Their simple preparation and commercial availability, combined 
with their diverse reactivity profile, have made them attractive 
starting materials that have been utilised within a range of 
synthetic protocols. When utilised in Lewis base catalysis, 
addition to the β-carbon of an allenoate generates a zwitterionic 
intermediate that shows remarkably diverse reactivity with a 
range of electrophilic coupling partners such as Michael-
acceptors, dipolarophiles or strained heterocycles. Lewis Basic 
phosphines have been widely explored as catalysts in such 
processes,[1c, 2] while the use of tertiary amine Lewis bases has 
been relatively less explored and typically show different 
reaction profiles to phosphines. Within the latter area, Borhan 
and co-workers first demonstrated the use of cinchona alkaloids 
to catalyse the formal [4+2] cycloaddition of allenoates and 
chalcones.[3] For example, quinidine catalysed the reaction of 
chalcone 3a (R1 = R3 = Ph, R2 = H) and allenoate 1a leading to 
the desired dihydropyran 4a in 83% yield and 95% ee. 
(Scheme 1a). Tong and co-workers extended this protocol 
through the introduction of a cyano-group in the α-position of the 
chalcone (3b, R1 = R3 = Ph, R2 = CN),[4] generating the 
corresponding dihydroparan 4b from allenoate 1b in 90% ee. 
Shi and co-workers subsequently utilised α-ketoesters 3c 
(R1 = Ph, R2 = H, R3 = COOtBu)[5] and α-ketophosphonates 3d 
(R1 = Ph, R2 = H, R3 = P(O)(OiPr)2)[6] as cycloaddition partners 
with allenoate 1a using tertiary amine catalysts, generating 
dihydropyrans 4c and 4d in up to 94% ee. The benefits of 
incorporating the trifluoromethyl group within target molecules 
such as increased chemical and metabolic stability, increased 
lipophilicity, and binding selectivity, are widely recognised and 
applied in medicinal chemistry.[7] In this context it has previously 
been demonstrated that 1,1,1-trifluoro- and 4,4,4-
trifluorobutenones can act as reactive reaction partners in 
cinchona alkaloid catalysed processes[8] as well as in 
isothiourea[9] and NHC-mediated[10] [4+2] cycloaddition 
processes. Building upon this precedent, in this manuscript the 
catalytic enantioselective formal [4+2]-cycloaddition of 
allenoates with regioisomeric 1,1,1-trifluoro- and 4,4,4-
trifluorobutenones is demonstrated for the preparation of 
stereodefined C(6)- and C(4)-trifluoromethyl substituted 
dihydropyrans (Scheme 1b). Derivatisation of the products 
through chemo- and stereo-selective hydrogenation is also 
demonstrated.  
  
Scheme 1. Cinchona alkaloid-catalysed formal [4+2] cycloadditions of 
allenoates and enones. 
Results and Discussion 
Synthesis of C(6)-trifluoromethyl dihydropyrans: 
Optimisation: 
Initial studies probed the ability of a variety of cinchona alkaloid 
derivatives as catalysts for the formal [4+2] cycloaddition of 
allenoates and 1,1,1-trifluorobut-3-en-2-ones. The reaction of 
ethyl 2,3-butadienoate 1a and 1,1,1-trifluoro-4-phenylbut-3-en-2-
one 5a to give 7a was chosen as a model system for reaction 
optimisation. A range of cinchona alkaloids was screened for 
catalytic activity and product enantioselectivity (Table 1). 
Quinidine 6a and quinine 6b behaved similarly giving the 
antipodic products 7a and 7a(ent) in good yields and promising 
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enantioselectivity (entries 1 and 2, up to 83% ee). cinchonine 6c 
and cinchonidine 6d, which lack the phenolic methoxy-
substituent, showed a significant decrease in product ee 
(entries 3 and 4, both 37% ee). Bulkier 9-O-protected quinidine 
derivatives were also screened; with 9-O-methylnaphthyl-
quinidine 6e and 9-O-trimethylsilylquinidine 6f resulted in lower 
product yield with comparable product enantioselectivities 
(entries 5 and 6). The effect of temperature on the reaction was 
also evaluated using quinidine as the catalyst. Notably, a 
reduction in temperature to 0 °C led to a marginal increase in ee, 
while a substantial loss in product conversion and isolated yield 
was observed at −78 °C (entries 1, 7 and 8). 
Table 1. Catalyst screen  
 
entry catalyst[a] T [°C] yield [%][b] ee [%][c] 
1 6a     rt 78 76 
2 6b     rt 76 83 
3 6c     rt 64 37 
4 6d     rt 36 37 
5 6e     rt 78 80 
6 6f     rt 36 83 
7 6a     0 67 81 
8 6a −78 16 79 
[a] 20 mol%. [b] Isolated yield. [c] Determined by HPLC analysis against 
racemic sample. 
 
Due to the recognised influence of the reaction solvent on 
cinchona alkaloid conformation and therefore product ee, an 
extensive solvent screen of this reaction process was 
performed.[11] At room temperature polar protic solvents such as 
methanol and ethanol (Table 2, entries 1 and 2) gave highest 
enantioselectivity (91% ee and 89% ee respectively), although 
methanol required extended reaction times and only gave 
product in 33% yield. Using 10 or 5 mol% of quinidine in ethanol 
the product ee remained approximately constant although 
reduced product conversion and isolated yield were observed 
(entries 3 and 4). Aprotic polar solvents exhibited an increase in 
reaction rate with good yields but only moderate 
enantioselectivity (entries 5 - 9). The use of ethyl acetate or 
toluene gave good conversion in short reaction times (maximum 
5 hours, entries 10 - 11), although moderate enantio-selectivities 
were observed. Performing the reaction with water as the 
solvent gave low selectivity in favour of 7a(ent) (entry 12). In an 
attempt to further improve the product enantioselectivity and 
reaction rate, a range of additives was tested in either ethanol or 
toluene as the solvent (entries 13 - 15). Marginally improved ee 
was observed when 20 mol% of benzoic acid, phenol or 
hexafluoro-iso-propanol (HFIP) were used in ethanol (95 - 
91% ee), but lower yields were obtained. As a compromise 
between product ee and yield, as well as reaction rate, ethanol 
was chosen as the optimum solvent for this transformation. 
Table 2. Solvent and additive screen for the reaction of 1a with 5a. 
 
entry solvent[a] Additive[b] t [h] yield [%][c] ee [%][d] 
  1 MeOH -   72 33 91 
  2 EtOH -   48 68 89 
     3[e] EtOH -   72 45 88 
    4[f] EtOH - 192 46 90 
  5 CH2Cl2 - 114 82 85 
  6 acetone -   47 79 82 
  7 MeCN -   21 77 79 
  8 THF -   15 78 76 
  9 Et2O -   20 80 75 
10 EtOAc -     5 73 83 
11 toluene -     4 85 79 
12 H2O -     2 55 18(ent) 
13 EtOH PhCOOH   96 49 95 
14 EtOH HFIP   48 63 93 
15 EtOH PhOH   48 52 91 
[a] 0.1 M. [b] 20 mol%. [c] Isolated yield. [d] Determined by 
HPLC analysis against racemic sample. [e] 10 mol% 6a (QD). 
[f] 5 mol% 6a (QD). 
 
The relative and absolute configuration at C(4) was 
unambiguously identified to be (S)-7a through X-ray 
crystallographic analysis, with the configuration within all 
subsequent examples assigned by analogy (Figure 1).[12] 
 







Figure 1. Molecular representation of the X-ray crystallographic analysis of 
(S)-7a. 
Scope and Limitations:  
I. Using 1,1,1-trifluorobut-3-en-2-ones as the reaction 
component 
Having developed optimum reaction conditions in the model 
system, the scope of the reaction was probed through variation 
with the trifluoromethylenone (Table 3). Generally, good yield 
and high product enantioselectivity were obtained with a range 
of substituted C(4)-aromatic and heteroaromatic substituents 
within the enone. Phenyl-, 1-, and 2-naphthyl-substituents gave 
essentially identical yields and product ees (7a - 7c). The 
incorporation of a bromine in the o-, m- and p-position of the 
phenyl-substituent was tolerated (7d – 7f), although 
o-substitution led to reduced product yield and enantioselectivity. 
 
Table 3. Scope for the reaction of 1 with 1,1,1-trifluoromethylbut-3-en-2-ones. 
With strongly electron-withdrawing p-nitrophenyl- and p-mesyl-
phenyl-substituents lower product ees were observed (7g, 7h), 
whilst high ee but reduced product conversion was obtained with 
an electron-rich p-anisyl- or p-tolyl-substituent (7i, 7j). Pleasingly, 
heteroaromatic and aliphatic substituents such as thienyl (7k) 
and pentyl groups (7l) were also tolerated, however slow 
conversion to product, resulting in lower isolated yield, was 
observed with n-pentyl-alkyl substitution (7l). 
Further studies probed the challenging effect of introducing 
an α-methyl substituent within the enone moiety (Table 4). Due 
to a significant decrease in reaction rate in EtOH, toluene was 
chosen as the reaction solvent, although long reaction times (5-
10 days) were required for significant product formation. 
However, all products 9a – 9g were prepared in excellent 
enantioselectivity. Notable trends indicate that electron-
withdrawing p-nitrophenyl substituent gave high product 
conversion and yield (9g), whilst a significant decrease in 
product yield was observed for the o-bromophenyl- compared to 
the p-bromosubstituted analogue (9e and 9f). 
 
Table 4. Scope for the reaction of 1a with 3-methyl-1,1,1-trifluoromethylbut-3-
en-2-ones. 
II. Using isomeric 4,4,4-trifluorobut-2-en-1-ones as the 
reaction component  
Having developed methodology utilising 1,1,1-trifluorobut-3-en-
2-ones for the preparation of C(6)-trifluoromethyl dihydropyrans, 
the use of isomeric 4,4,4-trifluorobut-2-en-1-ones for the 






preparation of stereodefined C(4)-trifluoromethyl substituted 
dihydropyrans was investigated (Table 5). A brief investigation of 
the effect of solvent using quinidine 6a as the catalyst revealed 
that the reaction proceeded to give the product in good ee in a 
range of solvents. Acetone provided the best compromise 
between high yield and enantioselectivity. 
Table 5. Solvent screen for the reaction of 1a with 10a. 
 
entry solvent[a] t [d] yield [%][b] ee [%][c] 
1 toluene 1 71 85 
2 EtOH 6 21 95 
3 THF 2 79 84 
4 CH2Cl2 6 72 89 
5 acetone 2 74 92 
6 MeCN 2 80 88 
7 AcOEt 4 74 89 
[a] 0.1 M. [b] Isolated yields. [c] Determined by chiral HPLC analysis against 
racemic sample. 
Using acetone as the reaction solvent, the generality of this 
procedure was next examined (Table 6). Good yields and 
excellent enantioselectivities were generally obtained with 
aromatic and heteroaromatic substituents (11a – 11e). Only p-
nitrophenyl substitution exhibited modest enantioselectivity, 
consistent with the selectivity observed in the isomeric series. 
 
Table 6. Scope for the reaction of 1a with 4,4,4-trifluoromethylbut-2-en-1-ones. 
Consistent with the computational work of Yu et al. we postulate 
the mechanism of this transformation proceeds via the addition 
of the tertiary amine Lewis base to the β-position of the allenoate 
1a (Figure 2).[13] The resultant adduct I subsequently reacts in 
an s-cis conformation with the enone 5a with the resultant 
enolate II undergoing cyclisation to give the 6-membered ring 
III. Final elimination results in regeneration of the cinchona 
catalyst and formation of dihydropyran product 7a. 
  
Figure 2. Postulated mechanism for amine catalysed formal [4+2] 
cycloaddition of allenaotes and enones. 
Product Derivatisation: 
The tetrahydropyran motif is present in many bioactive 
molecules, such as the anti-osteoporotic diospongine, making 
methods for accessing these architectures highly desireable.[14] 
To showcase the utility of the methodology developed in this 
manuscript, derivatisation of 7a and 11a to enantioenriched 
tetrahydropyran scaffolds via hydrogenation was investigated 
(Scheme 2). Treatment of 7a (87% ee) with Pd/C and H2 (1 atm) 
gave a 75:25 mixture of tetrahydropyran diastereoisomers 12 
and 13 in 80% combined yield. However, hydrogenation of 7a 
(83% ee) using Wilkinson’s catalyst (50 bar H2, 60 °C) 
selectively reduced the exocyclic olefin, giving 14 in 93% yield 
and >95:5 d.r. Further hydrogenation of 14 with Pd/C gave 12 in 
>95:5 d.r. and 74% yield. The relative configuration within 12 – 
15 and 17 was confirmed by nOe and Karplus analyses.[15] 
 






Scheme 2. Selective hydrogenation of dihydropyran 7a using Pd/C and 
Wilkinson’s catalyst. 
The same protocols were applied to dihydropyran 11a. Using 
Pd/C as the catalyst a separable 55:45 mixture of 
tetrahydropyran 15 (>95:5 dr) and ring-opened product 16 in 
74% combined yield.[15-16] The formation of 16 presumably arises 
from hydrogenation, followed by benzylic hydrogenolysis.[17] 
However, treating 11a with Wilkinson’s catalyst gave the 
expected mono-hydrogenated dihydropyran 17 in 77% yield and 
>95:5 d.r. Notably 15 and 17 showed no loss of stereointegrity 




Scheme 3. Selective hydrogenation of dihydropyran 11a using Pd/C and 
Wilkinson’s catalyst. 
Conclusions 
To conclude, quinidine promotes the catalytic enantioselective 
formal [4+2] cycloaddition of allenoates with isomeric 1,1,1-
trifluoro- and 4,4,4-trifluoromethylbutenones, allowing the 
preparation of stereodefined C(4)- and C(6)-trifluoromethyl 
substituted dihydropyrans with high enantioselectivity. The 
scope and limitations of these processes has been widely 
explored giving the corresponding dihydopyrans in moderate to 
good yield and good to excellent enantioselectivity. The 
dihydropyran products can be reduced selectively using Pd/C or 
Wilikinson’s catalyst to give the corresponding tetra- and 
dihydropyrans.  
Experimental Section 
Example procedure for the enantioselective organocatalytic generation of 
dihydropyrans: 
To a stirred solution of ethyl 2,3-butadienoate 1a (0.12 mmol) and the 
appropriate enone (0.10 mmol) in the appropriate solvent (0.1 M) was 
added quinidine 6a (0.02 mmol) at room temperature. After stirring at 
room temperature the reaction mixture was quenched with ammonium 
chloride (s) and filtered. The solvent was removed in vacuo and the 
crude was submitted to column chromatography on silica gel (eluent 
petrol:CH2Cl2 4:1 unless otherwise stated) to yield desired dihydropyrans. 
 For general experimental details, full characterisation data, NMR spectra 
and HPLC traces, see the Supporting Information. 
Acknowledgements 
We thank the Royal Society for a University Research 
Fellowship (ADS) and the European Research Council under the 
European Union’s Seventh Framework Programme (FP7/2007-
2013), ERC Grant Agreement No. 279850 (KK), We also thank 
the EPSRC UK National Mass Spectrometry Facility at Swansea 
University.  
Keywords: organocatalysis • cinchona alkaloid catalysis • 
oxygen heterocycles • enantioselective catalysis • dihydropyrans  
[1] a) J. Ye, S. Ma, Acc. Chem. Res. 2014, 47, 989-1000; b) C. Aubert, L. 
Fensterbank, P. Garcia, M. Malacria, A. Simonneau, Chem. Rev. 2011, 111, 
1954-1993; c) Z. Wang, X. Xu, O. Kwon, Chem. Soc. Rev. 2014, 43, 2927-
2940; d) B. M. Trost, G. Kottirsch, J. Am. Chem. Soc. 1990, 112, 2816 - 2818; 
e) A. V. Gulevich, A. S. Dudnik, N. Chernyak, V. Gevorgyan, Chem. Rev. 2013, 
113, 3084-3213; f) N. Krause, C. Winter, Chem. Rev. 2011, 111, 1994-2009. 
[2] a) Y. Wei, M. Shi, Chem. Asian J. 2014, 9, 2720-2734; b) F. Lopez, J. L. 
Mascarenas, Chem. Soc. Rev. 2014, 43, 2904-2915; c) S. Xu, Z. He, RSC 
Adv. 2013, 3, 16885-16904; d) L.-W. Xu, ChemCatChem 2013, 5, 2775-2784; 
e) Z. Wang, O. Kwon, in Diversity-Oriented Synthesis, John Wiley & Sons, Inc., 
2013, pp. 97-133; f) C. K. Pei, M. Shi, Chem. Eur. J. 2012, 18, 6712-6716. 
[3] K. D. Ashtekar, R. J. Staples, B. Borhan, Org. Lett. 2011, 13, 5732 - 
5735. 
[4] a) X. Wang, T. Fang, X. Tong, Angew. Chem. 2011, 123, 5473 - 5476; 
b) X. Wang, T. Fang, X. Tong, Angew. Chem. Int. Ed. 2011, 50, 5361-5364. 
[5] C. K. Pei, Y. Jiang, M. Shi, Org. Biomol. Chem. 2012, 10, 4355-4361. 
[6] a) C.-K. Pei, Y. Jiang, Y. Wei, M. Shi, Angew. Chem. 2012, 124, 11490 
- 11494; b) C.-K. Pei, Y. Jiang, Y. Wei, M. Shi, Angew. Chem. Int. Ed. 2012, 
51, 11328 - 11332. 
[7] a) C. B. Kelly, M. A. Mercadante, N. E. Leadbeater, Chem. Commun. 
2013, 49, 11133-11148; b) G. K. S. Prakash, F. Wang, Chim. Oggi 2012, 30, 
30 - 37; c) H. Vorbrüggen, Helv. Chim. Acta 2011, 94, 947-965; d) M. 
Jagodzinska, F. Huguenot, G. Candiani, M. Zanda, ChemMedChem 2009, 4, 
49-51; e) S. Purser, P. R. Moore, S. Swallow, V. Gouverneur, Chem. Soc. Rev. 
2008, 37, 320-330; f) W. K. Hagmann, J. Med. Chem. 2008, 51, 4359-4369; g) 
D. B. Berkowitz, K. R. Karukurichi, R. de la Salud-Bea, D. L. Nelson, C. D. 
McCune, J. Fluorine Chem. 2008, 129, 731-742; h) K. Müller, C. Faeh, F. 
Diederich, Science 2007, 317, 1881-1886; i) B. K. Park, N. R. Kitteringham, P. 






M. O'Neill, Annu. Rev. Pharmacol. Toxicol. 2001, 41, 443-470; j) T. Hiyama, 
Organofluorine Compounds: Chemistry and Applications, Springer, New York, 
2000. 
[8] a) H. Kawai, S. Okusu, E. Tokunaga, H. Sato, M. Shiro, N. Shibata, 
Angew. Chem. 2012, 124, 5043-5046; b) H. Kawai, S. Okusu, E. Tokunaga, H. 
Sato, M. Shiro, N. Shibata, Angew. Chem. Int. Ed. 2012, 51, 4959-4962; c) H. 
Kawai, Z. Yuan, T. Kitayama, E. Tokunaga, N. Shibata, Angew. Chem. Int. Ed. 
2013, 52, 5575-5579; d) H. Kawai, Z. Yuan, T. Kitayama, E. Tokunaga, N. 
Shibata, Angew. Chem. 2013, 125, 5685-5689; e) Y.-Y. Huang, X. Yang, Z. 
Chen, F. Verpoort, N. Shibata, Chemistry – A European Journal 2015, 21, 
8664-8684. 
[9] a) L. C. Morrill, J. Douglas, T. Lebl, A. M. Z. Slawin, D. J. Fox, A. D. 
Smith, Chem. Sci. 2013, 4, 4146-4155; b) D. G. Stark, L. C. Morrill, P.-P. Yeh, 
A. M. Z. Slawin, T. J. C. O'Riordan, A. D. Smith, Angew. Chem. Int. Ed. 2013, 
52, 11642-11646; c) P.-P. Yeh, D. S. B. Daniels, D. B. Cordes, A. M. Z. Slawin, 
A. D. Smith, Org. Lett. 2014, 16, 964-967. 
[10] a) A. T. Davies, J. E. Taylor, J. Douglas, C. J. Collett, L. C. Morrill, C. 
Fallan, A. M. Z. Slawin, G. Churchill, A. D. Smith, J. Org. Chem. 2013, 78, 
9243-9257; b) A. T. Davies, P. M. Pickett, A. M. Z. Slawin, A. D. Smith, ACS 
Catal. 2014, 4, 2696-2700. 
[11] a) T. Bürgi, A. Baiker, J. Am. Chem. Soc. 1998, 120, 12920 - 12926; b) 
G. K. S. Prakash, F. Wang, C. Ni, J. Shen, R. Haiges, A. K. Yudin, T. Mathew, 
G. A. Olah, J. Am. Chem. Soc. 2011, 133, 9992-9995; c) G. K. S. Prakash, F. 
Wang, M. Rahm, Z. Zhang, C. Ni, J. Shen, G. A. Olah, J. Am. Chem. Soc. 
2014, 136, 10418-10431; d) F. Balzano, R. P. Jumde, A. Mandoli, S. Masi, D. 
Pini, G. Uccello-Barretta, Chirality 2011, 23, 784-795; e) H. Caner, P. U. 
Biedermann, I. Agranat, Chirality 2003, 15, 637-645. 
[12] Absolute configuration determined by X-ray analysis of 7a. CCDC 
1458381 contains the supplementary crystallographic data for this paper. 
These data can be obtained free of charge from The Cambridge 
Crystallographic Data Centre via www.ccdc.cam.ac.uk/data_request/cif. 
[13] a) G.-T. Huang, T. Lankau, C.-H. Yu, Org. Biomol. Chem. 2014, 12, 
7297 - 7309; b) G.-T. Huang, T. Lankau, C.-H. Yu, J. Org. Chem. 2014, 79, 
1700-1711. 
[14] a) S. Chandrasekhar, G. S. Kiran Babu, C. Raji Reddy, Tetrahedron: 
Asymmetry 2009, 20, 2216-2219; b) O. Piva, L. Raffier, F. Izquierdo, 
Synthesis 2011, 43, 4037-4044. 
[15] The relative configuration of these diastereoisomers was confirmed by 
nOe and Karplus analyses; for more details see supporting information. 
[16] Combined yield includes separated fractions of 15 (23% yield) and 16 
(22% yield) as well as the overlapping fractions. 
[17] a) S. Chen, A. A. Ibrahim, M. Mondal, A. J. Magee, A. J. Cruz, K. A. 
Wheeler, N. J. Kerrigan, Org. Lett. 2015, 17, 3248-3251; b) J. Yu, J. B. 
















[4+2]-cycloaddition of ethyl 
2,3-butadienoate with a 
range of 1,1,1-trifluoro- and 
4,4,4-trifluorobutenones is 
demonstrated for the 
preparation of stereodefined 
C(6) – and C(4)-
trifluoromethyl substituted 
dihydropyrans (up to 




Kevin Kasten,[a] David B. 
Cordes,[a] Alexandra M. Z. 
Slawin,[a] and Andrew D. 
Smith*[a] 
Page No. – Page No. 
Quinidine-Catalyzed 
Enantioselective Synthesis 







   
 
